estrogen therapy [topp]
Prevention [topp]
postmenopausal [tmco]
Women [popg]
placebo-controlled [resa]
Trial [resa]
Observational Study [resa]
Suggest [idcn]
Hormone replacement therapy [topp]
coronary heart disease [dsyn]
Trial [resa]
Low Risk [fndg]
Women [popg]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestagen [horm, phsu, strd]
Study [mnob]
Estrogen [horm, phsu, strd]
cardiac events [dsyn]
postmenopausal [tmco]
Women [popg]
SURVIVE [phsu]
First myocardial infarction [dsyn]
Methods [inpr]
Study [mnob]
Blinded [resa]
placebo-controlled [resa]
Secondary Prevention [topp]
Trial [resa]
postmenopausal [tmco]
Women [popg]
Age-Years [tmco]
N NOS [aapp, imft]
SURVIVE [phsu]
First myocardial infarction [dsyn]
Hospitals [hcro, mnob]
England [geoa]
Wales [geoa]
Women [popg]
Received [qlco]
Tablet [bodm]
Oestradiol valerate [horm, phsu, strd]
mg% [qnco]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
Daily [tmco]
Primary [qlco]
Cardiac Death [patf]
Mortality [qnco]
Intention [menp]
secondary [neop]
Uterine Bleeding [patf]
Endometrial Cancer [neop]
Stroke [dsyn]
Events [evnt]
Fractures [inpo]
findings [ftcn]
frequency [qnco]
Cardiac Death [patf]
treatment [ftcn]
Group [idcn]
months [tmco]
Ratio [qnco]
Cl - [elii]
P NOS [aapp, imft]
reduction [npop]
Mortality [qnco]
Take [hlca]
Estrogen [horm, phsu, strd]
placebo [topp]
Not significant [fndg]
P NOS [aapp, imft]
Relative Risk [qnco]
Cardiac Death [patf]
Lowest [qlco]
3 Months [tmco]
Post [tmco]
Recruitment [acty]
Interpretation [inpr]
Oestradiol valerate [horm, phsu, strd]
cardiac events [dsyn]
postmenopausal [tmco]
Women [popg]
SURVIVE [phsu]
Myocardial Infarction [dsyn]
